FdaApplication
ANDA 206266
Identifiers
- fda_app_no: ANDA206266
Properties
| Property | Value |
|---|---|
| applicant_name | PRINSTON PHARMACEUTICAL INC |
| application_type | ANDA |
| approval_date | 2022-03-28 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| FEBUXOSTAT | FEBUXOSTAT | 80MG | TABLET;ORAL |
| FEBUXOSTAT | FEBUXOSTAT | 40MG | TABLET;ORAL |
2 products